Clinical Trials in Zhejiang, China
Locations / Zhejiang, China
Delta Trials hosts 172 clinical trials conducted in Zhejiang, China, making it a notable site of clinical research activity. These trials covering 187 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 10 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Zhejiang.
172
Total Trials
187
Conditions
10
Terminated since 2020
Browse by condition (187 total)
- Breast cancer 12 trialsAll Breast cancer trials
- Non-small cell lung cancer 10 trialsAll Non-small cell lung cancer trials
- Triple negative breast cancer 4 trialsAll Triple negative breast cancer trials
- Advanced solid tumors 4 trialsAll Advanced solid tumors trials
- Gastric cancer 4 trialsAll Gastric cancer trials
- Ovarian cancer 4 trialsAll Ovarian cancer trials
- Carcinoma, non-small-cell lung 3 trialsAll Carcinoma, non-small-cell lung trials
- Chronic hepatitis b 2 trialsAll Chronic hepatitis b trials
- Platinum-resistant ovarian cancer 2 trialsAll Platinum-resistant ovarian cancer trials
- All Atherosclerotic cardiovascular disease trials
- Pancreatic cancer 2 trialsAll Pancreatic cancer trials
- Lymphedema 2 trialsAll Lymphedema trials
- Pancreatic cancer non-resectable 2 trialsAll Pancreatic cancer non-resectable trials
- Glioma, malignant 2 trialsAll Glioma, malignant trials
- Chronic myeloid leukemia 2 trialsAll Chronic myeloid leukemia trials
- Hepatocellular carcinoma 2 trialsAll Hepatocellular carcinoma trials
- Gastric ulcer 2 trialsAll Gastric ulcer trials
- Community-acquired pneumonia 2 trialsAll Community-acquired pneumonia trials
- Advanced solid tumor 2 trialsAll Advanced solid tumor trials
- Diffuse large B-cell lymphoma 2 trialsAll Diffuse large B-cell lymphoma trials